Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) showed up in the 13F filings of 104 institutional investors as of March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 31 Mar, 2026 | 2,344,971 | 0 | 0.00% | $22,019,278.00 |
| ORBIMED ADVISORS LLC | 31 Mar, 2026 | 1,737,287 | 140,000 | 8.76% | $16,313,125.00 |
| Aberdeen Group plc | 31 Mar, 2026 | 1,321,750 | 0 | 0.00% | $12,411,233.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 734,106 | 734,106 | 0.00% | $6,893,255.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 727,060 | -116,133 | -13.77% | $6,827,094.00 |
| DIADEMA PARTNERS LP | 31 Mar, 2026 | 439,957 | 439,957 | 0.00% | $4,131,196.00 |
| Stonepine Capital Management, LLC | 31 Mar, 2026 | 383,462 | -6,454 | -1.66% | $3,600,708.00 |
| ARMISTICE CAPITAL, LLC | 31 Mar, 2026 | 364,000 | -172,000 | -32.09% | $3,417,960.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 346,998 | -7,302 | -2.06% | $3,258,311.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Mar, 2026 | 333,415 | 105,589 | 46.35% | $3,130,767.00 |
| ADAR1 Capital Management, LLC | 31 Mar, 2026 | 331,781 | -241,781 | -42.15% | $3,115,424.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 271,636 | 3,590 | 1.34% | $2,550,662.00 |
| Exome Asset Management LLC | 31 Mar, 2026 | 234,136 | 94,593 | 67.79% | $2,198,537.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 187,029 | 16,156 | 9.45% | $1,757,021.00 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 31 Mar, 2026 | 160,462 | -21,600 | -11.86% | $1,506,738.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 146,596 | 69,050 | 89.04% | $1,376,537.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 136,602 | 59,248 | 76.59% | $1,281,362.00 |
| Persistent Asset Partners Ltd | 31 Mar, 2026 | 111,226 | 104,639 | 1,588.57% | $1,044,412.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Mar, 2026 | 108,792 | 48,603 | 80.75% | $1,016.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 107,800 | 70,735 | 190.84% | $1,012,242.00 |